DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Ketamine for Low Mood States in the ER

Phase 1

Completed

Conditions: Suicide Ideation
Depression

Interventions: Drug: ketamine

First Posted Date: 2010-09-27

Last Posted Date: 2020-08-24

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT01209845

Locations: 🇺🇸
Yale New Haven Hospital Emergency Department, New Haven, Connecticut, United States

Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

Phase 2

Completed

Conditions: Depression

Interventions: Drug: placebo
Drug: Riluzole

First Posted Date: 2010-09-17

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 104

Registration Number: NCT01204918

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Yale University, Yale Depression Research Program, New Haven, Connecticut, United States
🇺🇸
Massachussettes General Hospital, Depression Clinical and Research Center, Boston, Massachusetts, United States

Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.

Not Applicable

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Formoterol
Other: Placebo

First Posted Date: 2010-09-03

Last Posted Date: 2016-03-29

Lead Sponsor: Yale University

Target Recruit Count: 14

Registration Number: NCT01194479

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

Milestones of Adjustment Post-Psychosis

Phase 3

Terminated

Conditions: Quality of Life
Adjustment, Psychological
Signs and Symptoms
Schizophrenia
Medication Adherence

Interventions: Behavioral: Training in all modules including MAPP Recovery Model
Behavioral: Training in all modules except MAPP Recovery Model

First Posted Date: 2010-09-01

Last Posted Date: 2016-09-08

Lead Sponsor: Yale University

Target Recruit Count: 110

Registration Number: NCT01192594

Locations: 🇺🇸
The Connection Inc, New Haven, Connecticut, United States

Reproductive Medicine Network Biologic Specimen Repository

Completed

Conditions: Infertility

First Posted Date: 2010-08-12

Last Posted Date: 2015-03-04

Lead Sponsor: Yale University

Target Recruit Count: 1640

Registration Number: NCT01180387

Locations: 🇺🇸
University of Alabama Birmingham, Birmingham, Alabama, United States
🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸
Hackensack University, Hackensack, New Jersey, United States

and more 12 locations

The Effects of Cannabidiol and ∆-9-THC in Humans

Early Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cannabidiol
Drug: Placebo
Drug: Delta-9-THC

First Posted Date: 2010-08-12

Last Posted Date: 2022-01-31

Lead Sponsor: Yale University

Target Recruit Count: 27

Registration Number: NCT01180374

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Phase 2

Completed

Conditions: Liver Neoplasms

Interventions: Device: TheraSphere, Yttrium-90 glass Microspheres

First Posted Date: 2010-08-06

Last Posted Date: 2017-08-28

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01177007

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Incentive-based Intervention for Smoking Cessation and Prevention in High Schools

Phase 1

Completed

Conditions: Tobacco Prevention and Cessation

First Posted Date: 2010-08-02

Last Posted Date: 2012-07-04

Lead Sponsor: Yale University

Target Recruit Count: 1651

Registration Number: NCT01173835

Locations: 🇺🇸
CMHC, Substance Abuse Center, New Haven, Connecticut, United States

N-acetylcysteine (NAC) for Children With Tourette Syndrome

Phase 2

Completed

Conditions: Tourettes Syndrome
Tic

Interventions: Drug: N-Acetylcysteine (NAC)
Drug: Placebo

First Posted Date: 2010-07-29

Last Posted Date: 2017-02-10

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT01172288

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder

Phase 2

Completed

Conditions: Obsessive-Compulsive Disorder

Interventions: Other: Placebo
Drug: N-Acetylcysteine

First Posted Date: 2010-07-29

Last Posted Date: 2019-09-06

Lead Sponsor: Yale University

Target Recruit Count: 11

Registration Number: NCT01172275

Locations: 🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy